Radiopharmaceuticals, often also called radioligand therapy, are a critical precision medicine
approach to cancer treatment, employing targeted radiation to destroy harmful cells.
Understanding the nuances of this therapy can help patients make informed decisions. Here are
the top five facts about radioligand therapies patients should know:
Unlike traditional chemotherapy, which affects both cancerous and healthy cells,
radiopharmaceuticals are designed to specifically target diseased tissues. This targeting
stems from the radiopharmaceutical's ability to attach to certain proteins or receptors
found predominantly on cancer cells, allowing them to deliver a lethal dose of radiation
directly where it is needed. This precision helps reduce damage to healthy cells,
minimizing side effects.
